KAITLIN SCHILD: Open Payments
NPI 1356889182 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 16 payments from 5 companies in 2025. Trend: 2023 $1,205 · 2024 $863 · 2025 $562
Food & beverage: $477Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $277 |
| Janssen Biotech, Inc. | 3 | $131 |
| ABBVIE INC. | 3 | $83 |
| Aimmune Therapeutics, Inc. | 3 | $58 |
| Celltrion USA Inc. | 1 | $14 |
Products named: DUPIXENT, TREMFYA, ZENPEP, RINVOQ, SKYRIZI, VEGZELMA.
Industry payments across MO — which companies pay providers there.
